Dipen Maru Selected Research

CAN 508

4/2017

Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dipen Maru Research Topics

Disease

21	Neoplasms (Cancer) 04/2022 - 03/2008
16	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2011
12	Adenocarcinoma 04/2022 - 01/2004
9	Neoplasm Metastasis (Metastasis) 12/2020 - 03/2009
7	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 03/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2012
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2014
2	Pathologic Complete Response 11/2015 - 09/2010
2	Breast Neoplasms (Breast Cancer) 06/2013 - 03/2005
2	Carcinoma (Carcinomatosis) 09/2008 - 01/2004
1	Residual Neoplasm 01/2020
1	Carcinogenesis 12/2017
1	Barrett Esophagus (Barrett's Esophagus) 04/2017
1	Melanoma (Melanoma, Malignant) 12/2015
1	Microsatellite Instability 11/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2014
1	Polyps 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2010
1	Clinical Deterioration 05/2008
1	Stomach Neoplasms (Stomach Cancer) 05/2008

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2005
6	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2010
3	Biological ProductsIBA 01/2016 - 03/2008
2	Cetuximab (Erbitux)FDA Link 01/2021 - 01/2016
2	VemurafenibIBA 01/2021 - 12/2015
2	Bevacizumab (Avastin)FDA Link 12/2020 - 06/2013
2	Pharmaceutical PreparationsIBA 12/2019 - 11/2015
2	ErbB Receptors (EGF Receptor)IBA 12/2019 - 01/2016
2	Cyclin-Dependent Kinase 9IBA 07/2019 - 04/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 11/2015
1	RNA (Ribonucleic Acid)IBA 09/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	NucleotidesIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2019
1	Hematoxylin (Haematoxylon)IBA 12/2019
1	Anti-Idiotypic AntibodiesIBA 12/2019
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2018
1	ProteomeIBA 12/2017
1	CollagenIBA 12/2017
1	CC ChemokinesIBA 07/2017
1	LigandsIBA 07/2017
1	interleukin-21 (interleukin 21)IBA 07/2017
1	16S Ribosomal RNAIBA 07/2017
1	CytokinesIBA 07/2017
1	alvocidib (flavopiridol)IBA 04/2017
1	CAN 508IBA 04/2017
1	Codon (Codons)IBA 01/2016
1	Panitumumab (Vectibix)FDA Link 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 09/2014
1	src-Family KinasesIBA 09/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2014
1	PlatinumIBA 09/2014
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2014
1	hydrogen sulfite (bisulfite)IBA 01/2014
1	Bile Acids and Salts (Bile Acids)IBA 01/2014
1	MethyltransferasesIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013
1	Neuropilin-1IBA 06/2013
1	Fluorouracil (Carac)FDA LinkGeneric 09/2011
1	CRT 0066101IBA 05/2010
1	protein kinase DIBA 05/2010
1	beta CateninIBA 01/2004

Therapy/Procedure

15	Therapeutics 01/2021 - 03/2008
10	Drug Therapy (Chemotherapy) 12/2020 - 05/2008
4	Esophagectomy 04/2022 - 03/2008
4	Hepatectomy 12/2020 - 09/2014
2	Neoadjuvant Therapy 04/2022 - 02/2012
2	Chemoradiotherapy 01/2020 - 09/2010
1	Oral Administration 05/2010
1	Operative Surgical Procedures 02/2009
1	Radiotherapy 02/2009
1	Induction Chemotherapy 09/2008
1	Lymph Node Excision (Lymph Node Dissection) 03/2008